Valeant Puts Up $250M For Struggling Solta Medical
Valeant Pharmaceuticals International Inc. will buy cosmetics and body care company Solta Medical Inc. for about $250 million, the companies said Monday, in a deal that enables Valeant to add Solta's...To view the full article, register now.
Already a subscriber? Click here to view full article